Skip to main content

Healthcare and AI “Paradigm Shift” Stocks in Focus: IPA, MGRX, INBS, RMED

The healthcare sector has huge potential, offering attractive opportunities as companies meet the growing demand for Artificial Intelligence (AI) wellness solutions and recent market research is signaling the substantial potential for investors. A confluence of factors, including a rise in healthcare awareness, a paradigm shift in societal norms that emphasize self-care, and ground-breaking developments in medical technology, Artificial Intelligence (AI), and research, are just a few of the factors driving the growth in this sector.  This article examines 4 Nasdaq SmallCap Stocks to Watch.

ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) - Biotherapeutic research and technology company, which is driven by artificial intelligence. The company specializes in using the power of artificial intelligence to understand complex biological data in a better way and then speed up the development and discovery of unique antibodies.

ImmunoPrecise Antibodies (NASDAQ:IPA) – Unleashing the potential

This has placed the company right at the forefront of a cutting-edge industry and that is one of the reasons why many investors are now taking notice of ImmunoPrecise Antibodies. The core business of the company is involved with providing cutting-edge technologies for the purpose of comprehensive therapeutic antibody discovery and development. 

Recently the company announced that it had introduced a new transformative AI-driven rapid therapeutic screening platform. It had been developed through collaboration between the company's subsidiary BioStrand and IPA Canada. It was a significant new development since the platform aims to speed up the initial phase of drug discovery by eliminating the candidates with less promise. Such a platform would help companies in reducing costs significantly, save time and also minimize the risk of failure in the latter stages of the process.

Mangoceuticals Inc (NASDAQ: MGRX) - The stock was in action on Thursday and closed higher by 10.80% on a hefty volume of 44.74 million shares - over 13X its 10-day average volume.

Mangoceuticals is focused on the development, marketing, and selling of a range of men's health and wellness products and services and sells the product through a telemedicine platform.

The company announced on June 8 that it had been engaged as a sponsor for the 'Only Stans' podcast on Barstool Sports. Jabob Cohen, the Chief Executive Officer and co-founder of the company noted that everyone at the company was pleased to have the opportunity to sponsor the highly popular podcast.

Intelligent Bio Solutions Inc (NASDAQ: INBS) - is engaged in delivering intelligent, non-invasive, and rapid testing solutions. Its flagship product is the Intelligent Fingerprinting Drug Screening System, which has brought about a paradigm shift in testing by fingerprint sweat analysis.

Recently, the company added the synthetic opioid drug fentanyl and fentanyl-laced adulterated street drugs to the panel of substances that could be detected by its Intelligent Fingerprinting Drug Screening System. As per data from CDC, the number of overdose deaths in the United States in the 12 months ending November 2022 was more than 100,000. Out of those 81.9% of deaths had been brought about by opioids and fentanyl was the most common cause.

Ra Medical (NYSEAMERICAN: RMED) - The company works with its fully owned subsidiary unit Catheter Precision in the United States medical devices industry. The two entities are involved in producing devices that could help in the better treatment of cardiac arrhythmias.

Recently, the company completed its stock-for-stock merger with cardiac electrophysiology firm Catheter Precision. Catheter stakeholders will convert about $25 million of outstanding debt and all Catheter equity into non-voting convertible preferred stock of RA Medical, which is potentially convertible into approximately 15.4 million RA Medical common shares.



Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.“TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.